Convatec Group (CTEC)

Sector:

Health Care

Index:

FTSE 250

180.70p
   
  • Change Today:
    -7.20p
  • 52 Week High: 220.40
  • 52 Week Low: 147.00
  • Currency: UK Pounds
  • Shares Issued: 2,004.35m
  • Volume: 8,413,810
  • Market Cap: £3,621.86m
  • RiskGrade: 117

Geographical - by origin

  31-Dec-1931-Dec-1831-Dec-1731-Dec-1631-Dec-15
Revenue
Denmark271.9015%270.0015%298.0017%293.5017%289.7018%
Francen/an/an/an/an/an/a90.105%n/an/a
Other753.2041%752.6041%875.5050%493.1029%485.2029%
Switzerlandn/an/an/an/an/an/a110.807%n/an/a
U.K.n/an/an/an/an/an/an/an/a170.8010%
U.Sn/an/an/an/an/an/a543.8032%509.2031%
UK158.209%166.109%n/an/an/an/an/an/a
US643.9035%643.4035%591.1033%n/an/an/an/a
Unanalysedn/an/an/an/an/an/a157.009%195.5012%
Total 1,827.20100% 1,832.10100% 1,764.60100% 1,688.30100% 1,650.40100% 
 
Profit Before Tax
Unanalysed18.90100%201.20100%164.00100%(125.80)100%(110.30)100%
Total 18.90100% 201.20100% 164.00100% (125.80)100% (110.30)100% 

Geographical - by origin (turnover)

Product breakdown (turnover)

Product breakdown

  31-Dec-1931-Dec-1831-Dec-1731-Dec-1631-Dec-15
Revenue
AWC569.9031%587.5032%n/an/an/an/an/an/a
Advanced Wound Caren/an/an/an/an/an/a559.5033%536.1032%
Advanced wound caren/an/an/an/a577.8033%n/an/an/an/a
Continence & Critical Caren/an/an/an/an/an/a356.5021%348.2021%
Continence and Critical caren/an/an/an/a382.9022%n/an/an/an/a
Infusion Care275.6015%268.3015%n/an/an/an/an/an/a
Infusion Devicesn/an/an/an/a275.0016%260.2015%250.6015%
Ostomy Care525.0029%533.3029%528.9030%512.1030%515.5031%
ccc456.7025%443.0024%n/an/an/an/an/an/a
Total 1,827.20100% 1,832.10100% 1,764.60100% 1,688.30100% 1,650.40100% 
 
Profit Before Tax
Unanalysed18.90n/a201.20n/a164.00n/a(125.80)n/a(110.30)n/a
Total 18.90n/a 201.20n/a 164.00n/a (125.80)n/a (110.30)n/a 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page